Search

everythinglearnresearchcommunity

for

Search:↓

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

The skin microenvironment significantly affects hair growth and loss, offering potential treatment avenues.

Mechanical stimulation and new therapies show promise for hair regrowth.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Pattern mode isolation improves the reliability and predictability of Turing patterns.

Silver nanoparticles from Ostericum koreanum may help treat allergies.

Scientists successfully regenerated functional hair follicles using specific stem cells and mesenchymal cells.

Burn care for the elderly needs improvement, with more research and specific guidelines required.

Nanofiber scaffolds help wounds heal by delivering drugs directly to the injury site.

Lipedema is a painful fat disorder in women that's hard to treat, often worsens with hormonal changes, and requires symptom-focused therapies.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Hair gels may cause split ends in children.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Targeting Lgr5+ stem cells and Wnt signaling may effectively treat hair loss.

Imiquimod cream can rarely cause temporary hair loss.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Balancing testosterone may reduce COVID-19 severity.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Wnt/β-catenin signaling is crucial for cell fusion in placental development.

The postnatal thymus has cells like mesenchymal stem cells that can become different cell types and help maintain thymus structure.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.